Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165691 · ClinicalTrials.gov registry record · NA
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
A NA study of Lung Neoplasms, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT07165691: Recruiting NA study of Lung Neoplasms, sponsored by Rutgers, The State University of New Jersey.
NCT07165691 is a NA study of Lung Neoplasms that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 91 participants, below the 463-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07165691, a NA study of Lung Neoplasms, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer. Aim 2: Assess the feasibility, acceptability, and implementation potential of the culturally adapted TELESCOPE intervention delivered by bilingual patient navigators for Hispanics. Hypothesis 1: The investigators expect a recruitment rate of ≥60%, ≥90% of Hispanic participants will complete the 1-week follow-up assessments, ≥80% of the key intervention components will be delivered with 80% fidelity by the patient navigators, and ≥90% of participants and clinicians will agree or completely agree that the intervention was feasible and acceptable. Aim 3: Explore the impact of a culturally adapted TELESCOPE intervention delivered by bilingual patient navigators vs enhanced usual care (EUC) on the initial uptake of low-dose computed tomography (LDCT) and quality of the shared decision-making (SDM) process. Hypothesis 2: The investigators expect that an adapted TELESCOPE intervention will result in higher uptake of LDCT and higher SDM quality for lung cancer screening (LCS) compared to EUC.
Primary Outcome
The investigators expect a recruitment rate of ≥60%.
Conditions Studied
Interventions
- BEHAVIORAL TELESCOPE, Remote Decision Coaching with Navigation Intervention
Study Locations (1)
New Jersey
- Rutgers Cancer Institute - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT07165691 shows while recruiting
NCT07165691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 463-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which TELESCOPE, Remote Decision Coaching with Navigation Intervention is the first listed.
NCT07165691 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07165691 about?
NCT07165691 is a clinical study titled "TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics". Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk fo...
What is the current status of trial NCT07165691?
This trial is currently recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2025-09-11. Estimated completion is 2027-06-30.
What conditions does trial NCT07165691 study?
This clinical trial studies the following conditions: Lung Neoplasms.
What interventions are being tested in trial NCT07165691?
The interventions under investigation include: TELESCOPE, Remote Decision Coaching with Navigation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07165691?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07165691 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07165691's enrollment target sits among peer trials
91 10th of 22 higher than 13 of 22 other Lung Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
TELESCOPE- TELEhealth Shared Decision-making COaching
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Specimen Banking From Patients With Lung Cancer
RECRUITING
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI